Skip to content

Application of two-dimensional central and peripheral markers in precision diagnosis and prediction of Alzheimer's disease

Application of two-dimensional central and peripheral markers in precision diagnosis and prediction of Alzheimer's disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036644
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Gold Standard:Aß amyloid
p-Tau217,&#32
p-Tau181

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 50-75 years; 2) Main complaints of memory decline, in line with SCD questionnaire 1-5 standards; 3) MMSE >= 20 points; 4) Education years >= 6 years; 5) Able to cooperate with a full set of neuropsychological examinations; 6) Sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Meet the VASCOG diagnostic criteria of vascular cognitive impairment; 2) Definite diagnosis of other diseases that may cause cognitive impairment, such as Parkinson's disease, normal pressure hydrocephalus, vitamin B12 deficiency, hypothyroidism, etc. 3) Severe mental illness; 4) Severe depression: HDRS17 item score >= 24 points; 5) Severe heart, liver, kidney and other important organ diseases; 6) There is contraindication to PET-CT or cranial MRI.

Design outcomes

Primary

MeasureTime frame
plasma p-Tau 217;plasma p-Tau 181;Aß amyloid;Pathologic Tau;SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Secondary

MeasureTime frame
MRI burden score of CSVD;retinal microvascular abnormalities;Cognitive;Blood biochemical index;

Countries

China

Contacts

Public ContactXu Qun

Renji Hospital, School of Medicine, Shanghai Jiaotong University

xuqun628@163.com+86 13301679717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026